HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ruppert-Kohlmayr, A. J. Articles by Ruppert, G. S. Search for Related Content PubMed PubMed Citation Articles by Ruppert-Kohlmayr, A. J. Articles by Ruppert, G. S. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

Focal Nodular Hyperplasia and Hepatocellular Adenoma of the Liver

Differentiation with Multiphasic Helical CT

¹ Department of Radiology, University Hospital of Graz, Auenbruggerplatz 9, A-8036 Graz, Austria.
² Doors to Knowledge, Alte Reichsstr. 9, A-8410 Wildon, Austria.

OBJECTIVE. Differences of attenuation and enhancement patterns in focal nodular hyperplasia and hepatocellular adenoma were evaluated and quantified using triphasic single-slice helical CT.

MATERIALS AND METHODS. Forty-five histologically proven focal nodular hyperplasias in 27 patients and 18 hepatocellular adenomas in six patients were examined with helical CT. Quantitative evaluation included the following: attenuation of lesions, scar, and liver parenchyma during unenhanced, arterial (20 sec after injection), and portal venous phases (70 sec after injection); relative enhancement of lesions and liver (the ratio between attenuation in arterial phase and portal venous phase, respectively, and attenuation in unenhanced phase); and the prevalence of scar and its central vessel in focal nodular hyperplasia.

RESULTS. The study showed no significant difference between mean attenuation values of focal nodular hyperplasia (mean ± SD, 51.2 ± 5.9 H) and hepatocellular adenoma (mean ± SD, 56.3 ± 7.8 H) in the unenhanced phase. In the arterial phase attenuation values were significantly higher in focal nodular hyperplasia (mean ± SD, 117.9 ± 15.1 H) than in hepatocellular adenoma (mean ± SD, 80.1 ± 10.5 H). In the portal venous phase no significant differences in attenuation values were detected between focal nodular hyperplasia (mean ± SD, 112.1 ± 20.4 H) and hepatocellular adenoma (mean ± SD, 110.2 ± 12.9 H). For enhancement parameter thresholds separating focal nodular hyperplasia from hepatocellular adenoma, the following were found: the relative enhancement was higher in 100% of the focal nodular hyperplasias and lower than or equal to 1.6 (accuracy, 96%) in 87% of the hepatocellular adenomas.

CONCLUSION. Triphasic helical CT combined with quantitative evaluation of liver lesions offers the possibility of detecting differences in liver lesions that are visually similar on CT. The attenuation and relative enhancement in the arterial phase show significant differences that make accurate differentiation between focal nodular hyperplasia and hepatocellular adenoma possible.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. K. Kim, H.-J. Jang, P. N. Burns, J. Murphy-Lavallee, and S. R. Wilson Focal Nodular Hyperplasia and Hepatic Adenoma: Differentiation with Low-Mechanical-Index Contrast-Enhanced Sonography Am. J. Roentgenol., January 1, 2008; 190(1): 58 - 66. [Abstract] [Full Text] [PDF]

				A. J. Ruppert-Kohlmayr, M. Uggowitzer, T. Meissnitzer, and G. Ruppert Differentiation of Renal Clear Cell Carcinoma and Renal Papillary Carcinoma Using Quantitative CT Enhancement Parameters Am. J. Roentgenol., November 1, 2004; 183(5): 1387 - 1391. [Abstract] [Full Text] [PDF]